Avatar photo

Dr. D. Beard

DR. D. BEARD is specialist of Nash Pathology
  • Articles: 191
Videos & Slides: 0

The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review

In this systematic review, H. Gosal et al. (California Institute of Behavioral Neurosciences & Psychology, USA & Government Medical College, Amritsar, India) reviewed the effectiveness of the Mediterranean diet on NAFLD and its efficacy in disease management...
Read MoreThe Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review

Japan: NAFLD may affect half of the population by 2040

In this systematic review and meta-analytic approach combining study level with individual patient-level data, T. Ito et al. (Nagoya University Graduate School of Medicine, Japan) aimed to investigate the epidemiology of NAFLD in Japan with a focus on lean NAFLD. The overall NAFLD prevalence was 25.5%, and increased over time...
Read MoreJapan: NAFLD may affect half of the population by 2040

MAFLD or NAFLD: reasons and relevance of a single-letter change

Recently, a consensus recommended 'metabolic (dysfunction) associated fatty liver disease' as a more appropriate name to describe fatty liver disease associated with metabolic dysfunction (MAFLD). This single-letter change in the NAFLD acronym suggests that the old acronyms should be abandoned...

Read MoreMAFLD or NAFLD: reasons and relevance of a single-letter change

Prevalence of NAFLD and MAFLD in the US population

S. Ciardullo et G. Perseghin (Policlinico di Monza, and University of Milano Bicocca, Italy) performed a cross-sectional study of adults recruited in the 2017-2018 NHANES Survey, a representative sample of the general US population, in order to determine the prevalence of NAFLD, MAFLD and associated advanced fibrosis in the US population...
Read MorePrevalence of NAFLD and MAFLD in the US population

NAFLD: an increased risk of severe of COVID-19

This meta-analysis aimed to evaluate if MAFLD is associated with a more severe disease course of COVID-19. P. J. Hegyi et al. (Medical School, University, Pécs, Hungary) included nine studies in this quantitative and qualitative synthesis. MAFLD and NAFLD are associated with a more severe clinical picture of COVID-19. These results support...
Read MoreNAFLD: an increased risk of severe of COVID-19

From NAFLD to MAFLD: a premature change in terminology

Despite the substantial gains in our understanding of NAFLD/NASH over the past 2 decades, there has been some dissatisfaction with the terminology “non-alcoholic” which overemphasises “alcohol” and underemphasises the predisposing metabolic risk factors.
The term MAFLD is still suboptimal, leaving a great deal of ambiguity...
Read MoreFrom NAFLD to MAFLD: a premature change in terminology

CNS dysfunctions as extrahepatic manifestations of NAFLD/NASH

Increasing evidences suggest that a correlation exists between NAFLD/NASH and central nervous system diseases or dysfunctions such as depression, mild cognitive impairment, Alzheimer’s disease, and dementia. In this review, M. Colognesi et al. (University of Padova, Italy) summarise the main correlations...
Read MoreCNS dysfunctions as extrahepatic manifestations of NAFLD/NASH